Criteria of effective acid inhibition during antihelicobacter pharmacotherapy (according to the findings of express-gastro-pH-monitoring)
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 3
Abstract
Objective — to establish the criteria of pH values of express-gastro-pH-monitoring for successful eradication of Helicobacter pylori). Materials and methods. The analysis has been performed for the results of express-gastro-pH-monitoring in 49 patients with H. pylori-infected,acid-depended diseases of esophagus, stomach and duodenum. The patients were administered three-component anti-helicobacter pharmacotherapy in standard doses twice a day: proton pump inhibitor + clarithromycin + amoxicillin or ornidazole. The course of treatment was 7 days. Express-gastro-pH-monitoring was carried out on 6.7 ± 0.6 day of administration of three-component scheme of H. pylori eradication using Acidogastrograph AG-1рН and gastrointestinal electrode system, created by medical engineering team under the guidance of V. M. Professor Chernobroviy. The results of control 13C-urea breath test (IRIS, Wagner, Germany) the patients were divided into two groups: group 1 consisted of 39 patients (23 men and 16 women) with successful H. pylori eradication, and group two, involving 10 patients (5 men and 5 women) with failed anti-helicobacter treatment. The mean age of group 1 was 41.7 ± 2.7 years, height 171.2 ± 1.5 cm, body mass 70.5 ± 2.2 kg. The mean age in the group 2 was 46.4 ± 5.8 years, height 169.6 ± 2.1 cm, body mass 68.8 ± 2.6 kg. Results. During the express-gastro-pH-monitoring, in the group with unsuccessful H. pylori eradication (group 2) the mean values of intragastric pH > 5.0 units were observed only in 5 (12.5 %) measurement points (40, 41 cm during pH-microprobe insertion and 60, 59 and 58 cm during pH-microprobe removal), whereas in patients with successful H. pylori eradication (group 1) the mean values of intragastric pH > 5,0 were observed in all measurement points during insertion of pH-microprobe as well as during its excretion from the stomach. In patients with failed H. pylori eradication (group 2), the significantly lower (p < 0.05) indices of intragastric pH were observed comparing with patients with successful H. pylori eradication (group 1). In particular, min pH was (3.6 ± 0.45 vs 4.8 ± 0.33), max pH (of 5.6 ± 0.56 vs 6.8 ± 0.16), X pH (4.2 ± 0.61 vs 5.6 ± 0.28), Mo pH (3.9 ± 0.76 vs 5.7 ± 0.3) and Me pH (4.0 ± 0.55 vs 5.5 ± 0.3). The close correlation (р < 0.03) has been established between the successful H. pylori eradication and intragastric max pH index (r = 0.3) during anti-helicobacter pharmacotherapy, and (р < 0.05) between successful H. pylori eradication and mean intragastric pH X index (r = 0.27). Moreover, the correlation has been reveled (р < 0.03) between successful H. pylori eradication and increased intragastric pH Mo (r = 0.3). Conclusions. Express-gastro-pH monitoring can be used as a screening method for monitoring of antisecretory action of the efficacy of hydrochloric acid secretion blockers and forecasting of the successfulness of H. pylori eradication. The parameters of intragastric pH (based on the results of express-gastro-pH monitoring) in the course ofantihelicobacter pharmacotherapy) should be: max pH 6.8, X pH 5,6 and Mo pH 5.7, due to the close correlation established for these parameters and successful H. pylori eradication.
Authors and Affiliations
I. G. Paliy, V. M. Сhernobrovyi, S. V. Zaika, I. V. Chernova, N. M. Kondratiuk
Keywords
Related Articles
- EP ID EP615620
- DOI 10.30978/MG-2019-3-33
- Views 96
- Downloads 0
The modern paradigm of the chronic gastritis, associated with bile reflux
The authors considered the modern concepts of the mechanisms of formation and progression of chronic gastritis associated with bile reflux. The main factors responsible for the onset of duodenogastric reflux have been el...
Intestinal dysbiosis, obesity and metabolic syndrome: how to quit this tricky triangle?
The paper presents analysis of the data of worldwide literature, results of evidence-based experimental and clinical trials on the relationship between dietary habits and intestinal microbiota. The particular attention i...
The drug-induced injury of the upper gastrointestinal tract: prophylaxis and treatment
It is well established that non-steroidal anti-inflammatory drugs (NSAIDs) are the causal factor of mucosa damage not only of in the stomach and duodenum, but also in esophagus, triggering the development of gastroesopha...
Human microbiome: general information and clinical significance of digestive canal eubiosis
The resent investigations demonstrate the key role of the human microbiome in the formation of homeostasis, highlight the microbiota effects on a human immune system, its development and physiology, including organo- and...
Helicobacter pylori infection and acid-related diseases against the background of metabolic-associated conditions: mechanisms of development and management
The author presents data on the role of H. pylori infection in the initiation and progression of the changes in metabolic status of patients with type 2 diabetes mellitus (DM-2), insulin resistance, obesity, cardiovascul...